Policies & Publications: Prescribing Protocols

Title Document Number Last Reviewed
Acetylcysteine IV in Acute Paracetamol Overdose SESLHDPR/566
Acetylcysteine IV in non-paracetamol induced acute liver injury failure
Adenosine Protocol – Antiarrhythmic SESLHDPR/583
Agomelatine in major depression SESLHDPR/646
Apixaban SESLHDPR/588
Argatroban for Heparin Induced Thrombocytopenia (HIT) SESLHDPR/719
Aspirin IV in Neurointerventional Procedures and Intensive Care Areas SESLHDPR/700
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis SESLHDPR/699
Bedaquiline fumarate for resistant pulmonary tuberculosis SESLHDPR/672
Belatacept for prophylaxis of organ rejection in adult patients receiving/received a kidney transplant SESLHDPR/751
Bivalirudin for Heparin induced thrombocytopenia (HIT) SESLHDPR/711
Caplacizumab for severe thrombotic thrombocytopenic purpura SESLHDPR/713
Ceftaroline fosamil SESLHDPR/654
Ceftazidime-Avibactam SESLHDPR/698
Ceftolozane/tazobactam SESLHDPR/655
Colistimethate (Colistin) IV (Polymyxin E) for Urinary Tract Infections SESLHDPR/608
Dabigatran SESLHDPR/589
Danaparoid - Safe Use of SESLHDPR/600
Dinoprostone SESLHDPR/568
Empaglifozin for Type 2 Diabetes SESLHDPR/599
Entecavir for HBV reactivation in Renal Patients SESLHDPR/726
Evolocumab for familial hypercholesterolaemia SESLHDPR/594
Fentanyl 2microg/mL with Adrenaline (epinephrine) 2 microg/mL and Bupivacaine 0.1% epidural infusion SESLHDPR/637
Fidaxomicin for treatment of confirmed Clostridioides difficile infection (CDI) in adults SESLHDPR/710
Fomepizole for treatment of toxic alcohol (methanol, ethylene glycol) poisoning SESLHDPR/689
Fondaparinux for Heparin induced Thrombocytopenia (HIT) SESLHDPR/716
Fosfomycin Oral Prescribing Protocol SESLHDPR/661
Glargine - Safe Use of High Concentration Insulin Glargine 300 units/mL (Toujeo®) SESLHDPR/638
Idarucizumab in Urgent Dabigatran Reversal SESLHDPR/571
Levosimendan SESLHDPR/725
Lidocaine (lignocaine) patch for symptomatic treatment of neuropathic pain refractory or unsuitable for alternative medications SESLHDPR/648
Meglumine Diatrizoate and Sodium Diatrizoate (Gastrografin®) in Adult Adhesional Small Bowel Obstruction SESLHDPR/570
Micafungin for prevention and treatment of fungal infections in critically ill patients SESLHDPR/630
Naltrexone for treatment of long-acting opioid poisoning SESLHDPR/651
Ocrelizumab for Multiple Sclerosis SESLHDPR/629
Paracetamol SESLHDPR/717
Phentolamine in the treatment of dermal necrosis or sloughing following extravasation of peripherally administered noradrenaline (norepinephrine) SESLHDPR/602
Polymyxin B IV for infections outside of the urinary tract SESLHDPR/573
Ravulizumab SESLHDPR/684
Rivaroxaban SESLHDPR/601
Ryzodeg® - Insulin degludec/insulin aspart (Ryzodeg® 70/30) Prescribing Protocol SESLHDPR/650
Sacubitril+Valsartan (Entresto®) for Systolic Heart Failure SESLHDPR/585
Siponimod in the treatment of secondary progressive MS (SPMS) SESLHDPR/703
Sodium Thiosulfate in Calciphylaxis SESLHDPR/659
Standard short-course therapy for Tuberculosis (TB) with Fixed Dose Combination tablets SESLHDPR/657
Subcutaneous furosemide (frusemide) for end stage heart failure with fluid overload in the dying patient SESLHDPR/691
Subcutaneous levetiracetam for seizure management in palliative care patients SESLHDPR/692
Subcutaneous levomepromazine for refractory nausea in the palliative care patient and agitation in the terminal phase SESLHDPR/693
Subcutaneous lidocaine (lignocaine) for refractory neuropathic pain in the palliative care setting SESLHDPR/694
Subcutaneous phenobarbital for refractory terminal agitation and uncontrolled seizures (including status epilepticus) in the imminently dying patient SESLHDPR/695
Tapentadol in Moderate to Severe Pain SESLHDPR/587
Ticagrelor – Prevention of thrombotic complications post neurointerventional stenting procedures SESLHDPR/673
Tolvaptan in inpatient treatment of hyponatraemia SESLHDPR/576
Ulipristal Acetate for Emergency Contraception SESLHDPR/619
Ustekinumab for Crohn's Disease SESLHDPR/611
Varenicline for smoking cessation SESLHDPR/649
Zoledronic Acid for Early/Locally Advanced Breast Cancer
Zoledronic Acid in the treatment of Osteoporosis with fracture due to minimal trauma SESLHDPR/720